In the Caucasian population, approximately 25% patients with EVA/IP2 and HL have biallelic pathogenic variants of SLC26A4 (M2) and another 25% of patients carry a monoallelic SLC26A4 variant (M1) [26,27,28]. The gene discussed is SLC26A4; the disease is Hodgkins lymphoma.